Patents by Inventor Ken-ichiro Miyagawa

Ken-ichiro Miyagawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030087324
    Abstract: A hybridoma which produces a monoclonal antibody against an endocrine disruptor or its degradation product obtained by fusing spleen cells or lymphoid cells of an animal having been immunized with a complex of the endocrine disruptor or a compound similar thereto with a protein with myeloma cells; the monoclonal antibody produced thereby; and a method for immunologically detecting the endocrine disruptor or its degradation product and a method for immunologically concentrating the same each by using the above antibody.
    Type: Application
    Filed: October 15, 2002
    Publication date: May 8, 2003
    Inventors: Yukio Toyoda, Masanori Fujita, Yasuhiro Goda, Ken-Ichiro Miyagawa, Shigeru Fujimoto, Ayako Kobayashi, Katsuji Fukuda
  • Patent number: 6423869
    Abstract: A compound of the formula (I): wherein R1 represents an amino group which may be substituted; R2 represents a carboxy group which may be esterified or amidated; R3, R4, R5 and R6 each represent a hydroxy group which may be protected; Q represents an aryl group which may be substituted; or a salt thereof is disclosed. The compound (I) possesses ant-Helicobacter pylori activity, and is useful in the prevention or treatment of various diseases associated with Helicobacter bacteria, such as duodenal ulcer, gastric ulcer, chronic gastritis and cancer of the stomach.
    Type: Grant
    Filed: November 1, 1999
    Date of Patent: July 23, 2002
    Assignee: Takeda Chemical Industries, Inc.
    Inventors: Ken-ichiro Miyagawa, Shigetoshi Tsubotani, Masafumi Nakao, Yoshitaka Nakano, Keiji Kamiyama, Motoo Izawa, Yohko Akiyama, Yuji Nishikimi
  • Patent number: 6387687
    Abstract: A microorganism having indolmycin-producing ability and tryptophan analogue resistance is provided, and indolmycin or its salt can be produced efficiently by cultivating such microorganism in a medium to produce and accumulate indolmycin or its salt in the culture broth followed by recovering a product.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: May 14, 2002
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Akihiko Naotsuka, Motoo Izawa, Ken-ichiro Miyagawa
  • Patent number: 6251612
    Abstract: A hybridoma obtainable by fusing a spleen cell or lymphocyte of an animal immunized by a complex of a surfactant compound for synthetic detergent and protein with a myeloma cell, which produces a monoclonal antibody against the compound or its degradation product. A monoclonal antibody against a surfactant compound for synthetic detergent or its degradation product which is produced by the hybridoma, a kit for immunoassay of detergent, its degradation product or a mixture thereof containing as an essential constitutional component the monoclonal antibody, and an immunoassay method, in particular, ELISA of detergent, its degradation product or a mixture thereof in a specimen by reacting the specimen with the monoclonal antibody supported on a carrier and the detergent, its degradation product or the mixture thereof labeled with a labeling agent are also disclosed.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: June 26, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Yukio Toyoda, Masanori Fujita, Yasuhiro Goda, Ken-ichiro Miyagawa, Shigeru Fujimoto